[Therapeutic study of clofibrate during pituitrin-sensitive diabetes insipidus in children].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002994:Clofibrate / Q000627:therapeutic use; D003404:Creatinine; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004231:Diuresis / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D009994:Osmolar Concentration; D011422:Propionates / Q000627:therapeutic use*; D014667:Vasopressins / Q000032:analysis / Q000627:therapeutic use; D014867:Water / Q000378:metabolism
D000924:Anticholesteremic Agents; D011422:Propionates; D014867:Water; D014667:Vasopressins; D003404:Creatinine; D002994:Clofibrate
Etude thérapeutique du clofibrate au cours des diabètes insipides pitresso-sensibles de l'enfant.